#raredisease — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #raredisease, aggregated by home.social.
-
"AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" https://doi.org/10.37044/osf.io/e5g6s_v1
#biohackathon #ai #MHA26 #rareDisease
'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." https://index.biohackrxiv.org/2026/09/04/e5g6s.html
-
"AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" https://doi.org/10.37044/osf.io/e5g6s_v1
#biohackathon #ai #MHA26 #rareDisease
'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." https://index.biohackrxiv.org/2026/09/04/e5g6s.html
-
"AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" https://doi.org/10.37044/osf.io/e5g6s_v1
#biohackathon #ai #MHA26 #rareDisease
'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." https://index.biohackrxiv.org/2026/09/04/e5g6s.html
-
"AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" https://doi.org/10.37044/osf.io/e5g6s_v1
#biohackathon #ai #MHA26 #rareDisease
'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." https://index.biohackrxiv.org/2026/09/04/e5g6s.html
-
"AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" https://doi.org/10.37044/osf.io/e5g6s_v1
#biohackathon #ai #MHA26 #rareDisease
'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." https://index.biohackrxiv.org/2026/09/04/e5g6s.html
-
https://www.europesays.com/ch/104626/ Novartis (SWX:NOVN) Wins Full FDA Nod For Fabhalta And Wider EU Itvisma Use #AcceleratedApproval #FDAApproval #GeneTherapy #IgANephropathy #InvestmentDecisions #KidneyDisease #KidneyFunction #Novartis #RareDisease #RegulatoryDecisions #SpinalMuscularAtrophy
-
Novartis (SWX:NOVN) Wins Full FDA Nod For Fabhalta And Wider EU Itvisma Use
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Novartis…
#Europe #EU #acceleratedapproval #EuropeanUnion #FDAapproval #genetherapy #IgAnephropathy #investmentdecisions #kidneydisease #kidneyfunction #Novartis #raredisease #regulatorydecisions #spinalmuscularatrophy
https://www.europesays.com/europe/96524/ -
Pfizer (PFE) Gets An Opening In ATTR CM After AstraZeneca Trial Failure
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
#EuropeSays #Britain #Europe #EU #AstraZeneca #ATTR-CM #cardiomyopathy #pfizer #raredisease
https://www.europesays.com/britain/81050/ -
https://www.europesays.com/britain/81050/ Pfizer (PFE) Gets An Opening In ATTR CM After AstraZeneca Trial Failure #AstraZeneca #ATTRCM #cardiomyopathy #pfizer #RareDisease